J2806 — Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms
J2806 is a HCPCS Level II code for injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2024 and is not valid on new claims.
This code has been terminated
CMS terminated J2806 on December 31, 2024. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J2806
- Long descriptor
- Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms
- Short descriptor
- Inj sincalide, maia, 5 mcg
- Added
- July 1, 2023
- Terminated
- December 31, 2024
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J2806
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2806 is not quite right, the correct code is very often within a few positions of it.
- J2797Injection, rolapitant, 0.5 mg
- J2798Injection, risperidone, (perseris), 0.5 mg
- J2799Injection, risperidone (uzedy), 1 mg
- J2800Injection, methocarbamol, up to 10 ml
- J2801Injection, risperidone (rykindo), 0.5 mg
- J2802Injection, romiplostim, 1 microgram
- J2804Injection, rifampin, 1 mg
- J2805Injection, sincalide, 5 micrograms
- J2810Injection, theophylline, per 40 mg
- J2820Injection, sargramostim (gm-csf), 50 mcg
- J2840Injection, sebelipase alfa, 1 mg
- J2850Injection, secretin, synthetic, human, 1 microgram
- J2860Injection, siltuximab, 10 mg
- J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
- J2910Injection, aurothioglucose, up to 50 mgterminated
- J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
Questions about J2806
What is HCPCS code J2806?
J2806 is a HCPCS Level II code for injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2806?
The CMS HCPCS file marks J2806 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J2806 still valid?
No. J2806 was terminated on December 31, 2024 and should not be used on new claims.